103 related articles for article (PubMed ID: 15654977)
21. Characterization of density-dependent regulation of the tyrosinase gene promoter: role of protein kinase C.
Mahalingam H; Watanabe A; Tachibana M; Niles RM
Exp Cell Res; 1997 Nov; 237(1):83-92. PubMed ID: 9417870
[TBL] [Abstract][Full Text] [Related]
22. In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter.
Bertolotto C; Bille K; Ortonne JP; Ballotti R
Oncogene; 1998 Apr; 16(13):1665-70. PubMed ID: 9582014
[TBL] [Abstract][Full Text] [Related]
23. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC
Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094
[TBL] [Abstract][Full Text] [Related]
24. Characterization of gene regulatory elements for selective gene expression in human melanoma cells.
Artuc M; Nürnberg W; Czarnetzki BM; Schadendorf D
Biochem Biophys Res Commun; 1995 Aug; 213(2):699-705. PubMed ID: 7646526
[TBL] [Abstract][Full Text] [Related]
25. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Spierings DC; de Vries EG; Vellenga E; de Jong S
Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
[TBL] [Abstract][Full Text] [Related]
26. Ircinin-1 induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells.
Choi HJ; Choi YH; Yee SB; Im E; Jung JH; Kim ND
Mol Carcinog; 2005 Nov; 44(3):162-73. PubMed ID: 16163705
[TBL] [Abstract][Full Text] [Related]
27. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events.
Latinis KM; Carr LL; Peterson EJ; Norian LA; Eliason SL; Koretzky GA
J Immunol; 1997 May; 158(10):4602-11. PubMed ID: 9144472
[TBL] [Abstract][Full Text] [Related]
28. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter.
Kirchhoff S; Sebens T; Baumann S; Krueger A; Zawatzky R; Li-Weber M; Meinl E; Neipel F; Fleckenstein B; Krammer PH
J Immunol; 2002 Feb; 168(3):1226-34. PubMed ID: 11801659
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis in neuroblastomas induced by interferon-gamma involves the CD95/CD95L pathway.
Annicchiarico-Petruzzelli M; Bernassola F; Lovat PE; Redfern CP; Pearson AD; Melino G
Med Pediatr Oncol; 2001 Jan; 36(1):115-7. PubMed ID: 11464861
[TBL] [Abstract][Full Text] [Related]
30. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
Fang D; Setaluri V
Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
[TBL] [Abstract][Full Text] [Related]
31. Cell density modulates apoptosis in human articular chondrocytes.
Kühn K; Hashimoto S; Lotz M
J Cell Physiol; 1999 Sep; 180(3):439-47. PubMed ID: 10430184
[TBL] [Abstract][Full Text] [Related]
32. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
Emiliusen L; Gough M; Bateman A; Ahmed A; Voellmy R; Chester J; Diaz RM; Harrington K; Vile R
Gene Ther; 2001 Jul; 8(13):987-98. PubMed ID: 11438833
[TBL] [Abstract][Full Text] [Related]
33. Indole-3-carbinol and ultraviolet B induce apoptosis of human melanoma cells via down-regulation of MITF.
Kim SY; Kima DS; Jeong YM; Moon SI; Kwon SB; Park KC
Pharmazie; 2011 Dec; 66(12):982-7. PubMed ID: 22312706
[TBL] [Abstract][Full Text] [Related]
34. An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy.
Sipo I; Hurtado Picó A; Wang X; Eberle J; Petersen I; Weger S; Poller W; Fechner H
J Mol Med (Berl); 2006 Mar; 84(3):215-25. PubMed ID: 16437213
[TBL] [Abstract][Full Text] [Related]
35. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
[TBL] [Abstract][Full Text] [Related]
36. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
[TBL] [Abstract][Full Text] [Related]
37. Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival.
Neuber K; Eidam B
Onkologie; 2006 Sep; 29(8-9):361-5. PubMed ID: 16974112
[TBL] [Abstract][Full Text] [Related]
38. Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.
Ebata T; Mogi S; Hata Y; Fujimoto JI; Yagita H; Okumura K; Azuma M
Eur J Immunol; 2001 May; 31(5):1410-6. PubMed ID: 11465097
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
40. Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.
Vad NM; Kandala PK; Srivastava SK; Moridani MY
Chem Biol Interact; 2010 Feb; 183(3):462-71. PubMed ID: 19944085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]